MedTech portfolio is growing at a CAGR (compounded annual growing rate) of 11%-13%. The company’s non-MedTech operations are ...

Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE: ABT) with an Outperform rating and a price ...

Every investor in Abbott Laboratories ( NYSE:ABT) should be aware of the most powerful shareholder groups. The group holding ...

We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Abbott ...

Compared to the aggregate P/E ratio of the 273.66 in the Health Care Equipment & Supplies industry, Abbott Laboratories Inc. has a lower P/E ratio of 35.76. Shareholders might be inclined to think ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Abbott Laboratories’ $33.4 million sanctions award imposed in a trademark infringement lawsuit survived Thursday as the ...

Abbott Laboratories closed $9.00 below its 52-week high ($121.64), which the company reached on March 8th.

In a federal tax court petition, Abbott rejects numerous "arbitrary, capricious and unreasonable" determinations the IRS made ...

The Department of Justice announced an investigation into Abbott Laboratories' Michigan plant which was at center of a nationwide formula shortage in 2022. Abbott is recalling several of its ready ...

Shares of Abbott Laboratories ABT inched 0.11% higher to $112.73 Thursday, on what proved to be an all-around favorable ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other buzzing AI health stocks. The economic impact of AI is projected to be substantial ...